Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology
Go back to Lilly to Acquire DICE Therapeutics to Advance Innovation in Immunology| (NYSE: DICE) | Delayed: 24.83 -0.01 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.84 | 52 Week High | $ | |||
| Open | $24.94 | 52 Week Low | $ | |||
| Day High | $25.00 | P/E | N/A | |||
| Day Low | $24.83 | EPS | $ | |||
| Volume | 2,119 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1115.70 -7.3 (0.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1123.00 | 52 Week High | $88.16 | |||
| Open | $1129.41 | 52 Week Low | $67.88 | |||
| Day High | $1131.44 | P/E | 258.26 | |||
| Day Low | $1113.29 | EPS | $4.32 | |||
| Volume | 1,837,997 | |||||
